SEC Comment Letter 0000000000-24-005277 to Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: May 9, 2024 · CIK: 0001106838 · Accession: 0000000000-24-005277
AI Filing Summary & Sentiment
File numbers found in text: 333-279095
Letter
United States securities and exchange commission logo May 9, 2024 Pankaj Mohan, Ph.D. Chief Executive Officer Sonnet BioTherapeutics Holdings, Inc. 100 Overlook Center, Suite 102 Princeton, NJ 08540 Re:Sonnet BioTherapeutics Holdings, Inc. Registration Statement on Form S-1 Filed May 3, 2024 File No. 333-279095 Dear Pankaj Mohan: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jessica Dickerson at 202-551-8013 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Steven M. Skolnick
Show Raw Text
United States securities and exchange commission logo
May 9, 2024
Pankaj Mohan, Ph.D.
Chief Executive Officer
Sonnet BioTherapeutics Holdings, Inc.
100 Overlook Center, Suite 102
Princeton, NJ 08540
Re:Sonnet BioTherapeutics Holdings, Inc.
Registration Statement on Form S-1
Filed May 3, 2024
File No. 333-279095
Dear Pankaj Mohan:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jessica Dickerson at 202-551-8013 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Steven M. Skolnick